World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
77
Citations
18546
World Ranking
18540
National Ranking
9237

Overview

Rodrigo Machado-Vieira is affiliated with The University of Texas Health Science Center at Houston in the United States. Their research primarily spans the fields of Medicine and Neuroscience, with significant contributions to Psychiatry and Mental Health, Biological Psychiatry, Neurology, Pharmacology, and Cognitive Neuroscience.

Their scholarly output focuses on several key topics, including:

  • Bipolar Disorder and Treatment
  • Tryptophan and brain disorders
  • Transcranial Magnetic Stimulation Studies
  • Electroconvulsive Therapy Studies
  • Treatment of Major Depression
  • Functional Brain Connectivity Studies
  • Mental Health Research Topics

Rodrigo Machado-Vieira has authored numerous research papers published in various venues. Among the recent papers are:

  • What we learn about bipolar disorder from large-scale neuroimaging: Findings and future directions from the ENIGMA Bipolar Disorder Working Group, 2020, Human Brain Mapping
  • Inflammatory signaling mechanisms in bipolar disorder, 2021, Journal of Biomedical Science
  • Home-based transcranial direct current stimulation treatment for major depressive disorder: a fully remote phase 2 randomized sham-controlled trial, 2024, Nature Medicine
  • A Randomized Trial of the N-Methyl-d-Aspartate Receptor Glycine Site Antagonist Prodrug 4-Chlorokynurenine in Treatment-Resistant Depression, 2020, The International Journal of Neuropsychopharmacology
  • Blood-based biomarkers of antidepressant response to ketamine and esketamine: A systematic review and meta-analysis, 2022, Molecular Psychiatry

The venues where their work is frequently published include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Journal of Affective Disorders
  • Molecular Psychiatry
  • Pharmaceuticals
  • European Neuropsychopharmacology

Rodrigo Machado-Vieira collaborates extensively with several researchers. Frequent co-authors include:

  • Jair C. Soares
  • Gregory Jones
  • Lokesh Shahani
  • Courtney M. Vecera
  • Sudhakar Selvaraj

Best Publications

  • A Randomized Add-on Trial of an N-methyl-d-aspartate Antagonist in Treatment-Resistant Bipolar Depression

    Nancy Diazgranados;Lobna Ibrahim;Nancy E. Brutsche;Andrew Newberg

  • Cortical abnormalities in bipolar disorder : An MRI analysis of 6503 individuals from the ENIGMA Bipolar Disorder Working Group

    D P Hibar;L T Westlye;L T Westlye;N T Doan;N T Doan;N Jahanshad

  • Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder.

    Nancy DiazGranados;Lobna A. Ibrahim;Nancy E. Brutsche;Rezvan Ameli

  • Dynamic regulation of mitochondrial function by glucocorticoids

    Jing Du;Yun Wang;Richard Hunter;Yanling Wei

  • Oxidative stress parameters in unmedicated and treated bipolar subjects during initial manic episode: a possible role for lithium antioxidant effects.

    Rodrigo Machado-Vieira;Ana Cristina Andreazza;Carlos Ivan Viale;Vanessa Zanatto

  • A potential role for pro-inflammatory cytokines in regulating synaptic plasticity in major depressive disorder.

    Rushaniya A. Khairova;Rodrigo Machado-Vieira;Jing Du;Husseini K. Manji

  • The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesis

    Rodrigo Machado-Vieira;Husseini K Manji;Carlos A Zarate

  • Brain aging in major depressive disorder: results from the ENIGMA major depressive disorder working group

    Laura K.M. Han;Richard Dinga;Richard Dinga;Tim Hahn;Christopher R.K. Ching

  • Ketamine and the next generation of antidepressants with a rapid onset of action

    Rodrigo Machado-Vieira;Giacomo Salvadore;Nancy DiazGranados;Carlos A. Zarate

  • Peripheral brain-derived neurotrophic factor (BDNF) as a biomarker in bipolar disorder: a meta-analysis of 52 studies

    Brisa S. Fernandes;Brisa S. Fernandes;Marc L. Molendijk;Marc L. Molendijk;Cristiano A. Köhler;Jair C. Soares

  • Glutamatergic Modulators: The Future of Treating Mood Disorders?

    Carlos Zarate;Rodrigo Machado-Vieira;Ioline Henter;Lobna Ibrahim

  • Decreased plasma brain derived neurotrophic factor levels in unmedicated bipolar patients during manic episode.

    Rodrigo Machado-Vieira;Marcelo O. Dietrich;Renata Leke;Vitor H. Cereser

  • Clinical and biochemical manifestations of depression: relation to the neurobiology of stress.

    Phillip W. Gold;Rodrigo Machado-Vieira;Maria G. Pavlatou

  • Rapid onset of antidepressant action: a new paradigm in the research and treatment of major depressive disorder.

    Rodrigo Machado-Vieira;Giacomo Salvadore;David A. Luckenbaugh;Husseini K. Manji

  • Ketamine and other N-methyl-D-aspartate receptor antagonists in the treatment of depression: a perspective review.

    Nicolas D. Iadarola;Mark J. Niciu;Erica M. Richards;Jennifer L. Vande Voort

  • Novel insights into lithium's mechanism of action: neurotrophic and neuroprotective effects.

    Jorge A. Quiroz;Rodrigo Machado-Vieira;Carlos A. Zarate;Husseini K. Manji

  • The Timing of Antidepressant Effects: A Comparison of Diverse Pharmacological and Somatic Treatments

    Rodrigo Machado-Vieira;Jacqueline Baumann;Cristina Wheeler-Castillo;David Latov

  • Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT-resistant major depression.

    Lobna Ibrahim;Nancy Diazgranados;David A. Luckenbaugh;Rodrigo Machado-Vieira

  • Anterior Cingulate Desynchronization and Functional Connectivity with the Amygdala During a Working Memory Task Predict Rapid Antidepressant Response to Ketamine

    Giacomo Salvadore;Brian R Cornwell;Fabio Sambataro;David Latov

  • The neurobiology of the switch process in bipolar disorder: a review.

    Giacomo Salvadore;Jorge A. Quiroz;Rodrigo Machado-Vieira;Ioline D. Henter

Frequent Co-Authors

Carlos A. Zarate
Carlos A. Zarate National Institutes of Health
Wagner F. Gattaz
Wagner F. Gattaz Universidade de São Paulo
David A. Luckenbaugh
David A. Luckenbaugh National Institutes of Health
Jair C. Soares
Jair C. Soares The University of Texas Health Science Center at Houston
Andre R. Brunoni
Andre R. Brunoni Universidade de São Paulo
Antônio Lúcio Teixeira
Antônio Lúcio Teixeira The University of Texas Health Science Center at San Antonio
Elizabeth D. Ballard
Elizabeth D. Ballard National Institutes of Health
Mark J. Niciu
Mark J. Niciu University of Iowa
Husseini K. Manji
Husseini K. Manji National Institutes of Health
André F. Carvalho
André F. Carvalho Centre for Addiction and Mental Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA opens doors to a variety of online degrees and alternative healthcare career pathways. Many students look for efficient ways to enter the workforce, and the fastest lpn program options online provide a quick route to becoming a Licensed Practical Nurse.

For those interested in mental health, pursuing an msn to pmhnp online program can help registered nurses specialize and expand their career opportunities in psychiatric care.

Students interested in healthcare leadership can consider a Master of Healthcare Administration (MHA). There are plenty of flexible and reputable options available among the best online mha programs. Affordability is also within reach, with guidance on the most affordable mha online programs for those mindful of tuition costs.

Choosing a related online degree can accelerate your professional journey and broaden your impact on healthcare, whether in direct patient care or healthcare administration.

Best Scientists Citing Rodrigo Machado-Vieira

Trending Scientists